News

IBM (IBM) reported $15.77 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 1.9%. EPS of $2.43 for the same period compares to $2.18 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $15.58 billion, representing a surprise of +1.23%. The company delivered an EPS surprise of +12.50%, with the consensus EPS estimate being $2.16.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how IBM performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Global financing: $169 million versus $181.54 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -8.7% change.
• Revenue- Consulting: $5.18 billion compared to the $5.31 billion average estimate based on four analysts. The reported number represents a change of +3.3% year over year.
• Revenue- Other: $38 million compared to the $68.09 million average estimate based on four analysts. The reported number represents a change of -25.5% year over year.
• Revenue- Infrastructure: $3.65 billion versus the four-analyst average estimate of $3.43 billion. The reported number represents a year-over-year change of +0.8%.
• Revenue- Software: $6.74 billion versus $6.58 billion estimated by four analysts on average.
• Revenue- Infrastructure Support: $1.30 billion compared to the $1.25 billion average estimate based on two analysts. The reported number represents a change of -7.1% year over year.
• Revenue- Hybrid Infrastructure: $2.40 billion versus $2.18 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +4.4% change.
• Revenue- Application Operations: $1.90 billion compared to the $2.02 billion average estimate based on two analysts. The reported number represents a change of +5.6% year over year.
• Revenue- Technology Consulting: $900 million versus $952.20 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -10% change.
• Revenue- Business Transformation: $2.40 billion compared to the $2.30 billion average estimate based on two analysts. The reported number represents a change of +4.4% year over year.
• Revenue- Hybrid Platform & Solutions: $4.60 billion versus the two-analyst average estimate of $4.60 billion. The reported number represents a year-over-year change of -2.1%.
• Revenue- Transaction Processing: $2.20 billion compared to the $2 billion average estimate based on two analysts. The reported number represents a change of +15.8% year over year.

View all Key Company Metrics for IBM here>>>

Shares of IBM have returned +7.1% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Zacks’ Top 3 Hydrogen Stocks

Demand for clean hydrogen energy is projected to reach $500 billion by 2030 and grow 5-FOLD by 2050. Want in? Zacks has targeted 3 diversified titans that could lead the way to becoming hydrogen powerhouses.

One has crushed the market over the past 25 years – up +2,400% to +380%.

Another already has capital commitments of $15 billion for low carbon hydrogen products through 2027 alone.

Our third pick soared to 52-week highs in Q4 2023 and has raised its dividend every year for over a decade.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.